Step-by-step reconstitution process This process applies to every vial size
A small number of participants experienced gallbladder-related events or temporary elevations in bilirubin, but most cases were manageable and did not require permanent discontinuation of treatment
Segn la Clnica Cleveland , las enfermedades cardiovasculares siguen siendo la principal causa de muerte en Estados Unidos
Overview: Where GLP-1 Litigation Stands Now As of 2026, GLP-1 drug litigation is in an active investigation and litigation and early case-building phase , with: growing numbers of individual claims coordinated legal review across jurisdictions increasing focus on severe gastrointestinal and organ injuries, NAION and Vision loss expanding expert and scientific analysis litigating the consolidated proceedings in state and federal court GLP-1 Lawsuit status update, July 6th, 2026 There have been no reported GLP-1 lawsuit settlements
There is also debate regarding the potential for harm associated with PCSK9i use in patients with a history of HF, possibly mediated via unwanted effects on cardiac metabolism
